Pharmaceutical
Human APIs Powder
- Respiratory Drugs Raw Material
- Antiviral Antibacterial
- Antipyretic Analgesics
- Antihistamine Drugs
- Antineoplastic
- Cosmetic Raw Material
OEM & ODM
Veterinary raw materials
Phone: 86-29-89601602
E-mail: sales28@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
Ritonavir Raw material powder
Product Overview:
Ritonavir, a potent oral inhibitor of human immunodeficiency virus-1 (HIV-1) and human immunodeficiency virus-2 (HIV-2) aspartic protease, blocks the polymeric protein required by the enzyme to promote the production of morphologically mature HIV particles, thereby keeping the HIV particles in an immature state, thereby slowing the spread of HIV in cells. To prevent the occurrence of new infections and delay the development of the disease. Ritonavir is generally effective in dovudin-sensitive and zidovudine and saquinavir resistant HIV strains.
Ritonavir Raw material powder Attributes
CAS:155213-67-5
MF:C37H48N6O5S2
MW:720.94
EINECS:605-001-5
Specification: 99% min Ritonavir powder
Sample:Ritonavir powder
Packaging:1kg/bag, 25kg/drum
Brand: Henrikang
Appearance:white
Storage: Cool Dry Place
Shelf Life: 2 Years
Test Method: HPLC
Ritonavir Raw material powder Details
Ritonavir Powder Usage and Synthesis.
Ritonavir alone or in combination with antiretroviral nucleosides can be used to treat human immunodeficiency virus-1 (HIV-1) infection in adults and children 2 years of age and older.
Ritonavir is an AIDS (HIV) protease inhibitor that inhibits the HIV protease so that the enzyme cannot process polymeric proteins and thus cannot produce mature HIV particles, slowing the spread of HIV between cells. Prevent the development of new infections and slow the progression of HIV.
Ritonavir is a CYP3A inhibitor that increases the blood concentration of drugs that can be metabolized by CYP3A. Commonly used as a synergist for CYP3A metabolized HIV-1 protease inhibitors to increase the blood concentration of co-used HIV-1 protease inhibitors.
Uses of Ritonavir.
Pharmacological action of Ritonavir.
Ritonavir is an inhibitor of HIV-1 and HIV-2 proteases. Inhibition of the HIV protease prevents the enzyme from processing and synthesizing gag-pol polymeric protein precursors, resulting in non-infectious immature HIV virus particles. This product is generally effective in both dovudine-sensitive and zidovudine and saquinavir resistant HIV strains.
Product Method of Bulk Ritonavir Powder.
